T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
WIX.com
WIX
$3.35B
| $31.1M | 0.01% |
396,935
+287
| +0.1% | +$19.8K |
|
777
Interparfums
IPAR
$3.7B
| $30.9M | 0.01% |
409,774
+62,297
| +18% | +$4.94M |
|
778
Monte Rosa Therapeutics
GLUE
$1.35B
| $30.7M | 0.01% |
3,763,386
-1,485,749
| -28% | -$13.6M |
|
779
Cognex
CGNX
$10.4B
| $30.7M | 0.01% |
741,123
-4,708,712
| -86% | -$213M |
|
780
Cavco Industries
CVCO
$4.67B
| $30.6M | 0.01% |
148,929
-729,545
| -83% | -$173M |
|
781
Oneok
OKE
$58.4B
| $30.5M | 0.01% |
595,495
-6,521
| -1% | -$388K |
|
782
Crown Holdings
CCK
$12.9B
| $30.3M | 0.01% |
374,296
+321,904
| +614% | +$30M |
|
783
Darden Restaurants
DRI
$25.4B
| $30.3M | 0.01% |
239,776
+14,652
| +7% | +$1.83M |
|
784
Acadia Healthcare
ACHC
$2.82B
| $30.3M | 0.01% |
387,100
-10,063,402
| -96% | -$804M |
|
785
HP
HPQ
$28.6B
| $30.2M | 0.01% |
1,212,659
-163,485
| -12% | -$5.02M |
|
786
Haemonetics
HAE
$4.11B
| $30.1M | ﹤0.01% |
405,973
+88,354
| +28% | +$6.34M |
|
787
Arch Capital
ACGL
$33.5B
| $30M | ﹤0.01% |
659,223
+38,991
| +6% | +$1.76M |
|
788
MaxLinear
MXL
$6.95B
| $30M | ﹤0.01% |
919,110
-1,469,582
| -62% | -$54.3M |
|
789
Diageo
DEO
$52.8B
| $30M | ﹤0.01% |
176,458
+23,894
| +16% | +$4.28M |
|
790
Uber
UBER
$155B
| $29.9M | ﹤0.01% |
1,130,108
+193,921
| +21% | +$5.36M |
|
791
Willis Towers Watson
WTW
$31B
| $29.9M | ﹤0.01% |
148,533
-245
| -0.2% | -$50.6K |
|
792
T. Rowe Price
TROW
$23.7B
| $29.8M | ﹤0.01% |
283,759
+9,263
| +3% | +$1.11M |
|
793
VanEck Oil Services ETF
OIH
$1.95B
| $29.7M | ﹤0.01% |
140,629
| – | – |
|
794
Dick's Sporting Goods
DKS
$18.1B
| $29.4M | ﹤0.01% |
280,674
+28,093
| +11% | +$2.86M |
|
|
WBA
795
DELISTED
Walgreens Boots Alliance
WBA
| $29.3M | ﹤0.01% |
932,783
+2,045
| +0.2% | +$75.8K |
|
796
Capri Holdings
CPRI
$1.77B
| $28.8M | ﹤0.01% |
750,354
-295,151
| -28% | -$13.8M |
|
797
Expeditors International
EXPD
$24.3B
| $28.6M | ﹤0.01% |
324,283
-5,442
| -2% | -$545K |
|
798
Twist Bioscience
TWST
$7.86B
| $28.6M | ﹤0.01% |
811,223
-447,171
| -36% | -$19M |
|
|
SNCY
799
DELISTED
Sun Country Airlines
SNCY
| $28.6M | ﹤0.01% |
2,098,037
-1,527,561
| -42% | -$28.6M |
|
800
CBRE Group
CBRE
$44B
| $28.4M | ﹤0.01% |
421,123
-2,613
| -0.6% | -$207K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.